Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): A taxonomic update and review of the literature

Medical Mycology

Volumn 48, Issue 3, 2010, Pages 546-556

  Taj Aldeen, Saad J ^a   Almaslamani, Muna ^b   Alkhalf, Abdullatif ^c   Al Bozom, Issam ^c   Romanelli, Anna M ^b   Wickes, Brian L ^b   Fothergill, Annette W ^d   Sutton, Deanna A ^d  

^a Mycology Unit   (United States)

^b Department of Laboratory Medicine and Pathology ^*  (Australia)

^c HAMAD MEDICAL CORPORATION   (Qatar)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cerebral phaeohyphomycosis; Rhinocladiella mackenziei

Indexed keywords

AMPHOTERICIN B; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; BRAIN ABSCESS; BREAST CARCINOMA; CRANIOTOMY; FUNGUS IDENTIFICATION; HUMAN; HUMAN TISSUE; MORTALITY; NONHUMAN; PHAEOHYPHOMYCOSIS; TAXONOMY;

ANTIFUNGAL AGENTS; ASCOMYCOTA; BRAIN ABSCESS; BREAST NEOPLASMS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; DEBRIDEMENT; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; FATAL OUTCOME; FEMALE; HEAD; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOCOMPROMISED HOST; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MIDDLE EAST; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

FUNGI; RAMICHLORIDIUM MACKENZIEI; RHINOCLADIELLA;

EID: 77950574970     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903383914     Document Type: Article

References (31)

1. Kantarcioglu AS, de Hoog GS. Infections of the central nervous system by melanized fungi: a review of cases presented between 1999 and 2004. Mycoses 2004; 47: 4-13.
2. Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004; 38: 206-216. (Pubitemid 38113028)
3. Garzoni C, Markham L, Bijlenga P, Garbino J. Cladophialophora bantiana: a rare cause of fungal brain abscess. Clinical aspects and new therapeutic options. Med Mycol 2008; 46: 481-486.
4. Sutton DA,Slifkin M, Yakulis R, Rinaldi MG. US case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identifi cation, therapy, and review of other known dematiaceous neurotropic taxa. J Clin Microbiol 1998; 36: 97-102.
5. Kantarcioglu AS, Guarro J, De Hoog GS. Central nervous system infections by members of the Pseudallescheria boydii species complex in healthy and immunocompromised hosts: epidemiology, clinical characteristics and outcome. Mycoses 2008; 51: 275-290. (Pubitemid 351802159)
6. Arzanlou M, Groenewald J Z, Gams W, et al. Phylogenetic and morphotaxonomic revision of Ramichloridium and allied genera. Stud Mycol 2007; 58: 57-93. (Pubitemid 47572400)
7. Campbell CK, Al-Hedaithy SSA. Phaeohyphomycosis of the brain caused by Ramichloridium mackenziei sp. nov. in Middle Eastern countries. J Med Vet Mycol 1993; 31: 325-332.
8. Khan ZU, Lamdhade SJ, Johny M, et al. Additional case of Ramichloridium mackenziei cerebral phaeohyphomycosis from the Middle East. Med Mycol 2002; 40: 429-433. (Pubitemid 34965663)
9. Al-Abdely HM, Alkhunaizi AM, Al-Tawfiq JA, et al. Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole. Med Mycol 2005; 43: 91-95.
10. Podnos YD, Anastasio P, De La Maza L, Kim RB. Cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (Ramichloridium mackenziei): Case report. Neurosurgery 1999; 45: 372-375.
11. White TJ, Bruns TD, Lee SB, Taylor JW. Amplifi cation and sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis N, Gelfand D, Sninsky J, White TC, eds. PCR-Protocols and Applications - A Laboratory Manual. New York: Academic Press, 1990; pp. 315-322.
12. Kurtzman CP, Robnett CJ. Identifi cation of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26s) ribosomal DNA gene. J Clin Microbiol 1997; 35: 1216-1223.
13. Peterson SW, Kurtzman CP. Phylogenetic relationships among species of the genus Issatchenkia kudriavzev. Antonie Van Leeuwenhoek 1990; 58: 235-240.
14. Clinical and Laboratory Standards Institute. Reference Methods for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard, 2nd edn. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
15. Kanj SS, Amr SS, Roberts GD. Ramichloridium mackenziei brain abscess: report of two cases and review of the literature. Med Mycol 2001; 39: 97-102. (Pubitemid 32192923)
16. Amir SS, Al-Tawfiq JA. Aspiration cytology of brain abscess from a fatal case of cerebral phaeohyphomycosis due to Ramichloridium mackenziei. Diagn Cytopathol 2007; 35: 695-699.
17. Kashgari TQ, Al-Miniawi H, Moawad Hanna MK. Cerebral phaeohyphomycosis caused by Ramichloridium mackenziei in the Eastern province of Saudi Arabia. Ann Saudi Med 2000; 20: 457-460. (Pubitemid 32851360)
18. Stahel G. The banana leaf speckle in Surinam caused by Chloridium musae nov. spec. and another related banana disease. Trop Agric 1937; 14: 42-44.
19. de Hoog GS. Rhinocladiella and allied genera. Stud Mycol 1977; 15: 1-140.
20. McGinnis MR, Schell WA. The genus Fonsecaea and its relationship to the genera Cladosporium, Phialophora, Ramichloridium and Rhinocladiella. Pan Am Health Org Sci Pub 1980; 396: 215-234.
21. de Hoog GS, Rahman MA, Boekhout T. Ramichloridium, Veronaea and Stenella: generic delimitation, new combinations and two new species. Trans Br Mycol Soc 1983; 81: 485-490.
22. Collette N, Van der Auwera P, Meunier F, et al. Tissue distribution and bioactivity of amphotricin B administered in liposomes to cancer patients. J Antimicrob Chemother 1991; 27: 535-548.
23. Ur-Rahman N, Mahgoub El Sh, Chagla AH. Fatal brain abscess caused by Ramichloridium obovoideum: report of three cases. Acta Neurochir (Wien) 1988; 93: 92-95.
24. Horre R, de Hoog GS. Primary cerebral infections by melanized fungi: a review. Stud Mycol 1999; 43: 176-193. (Pubitemid 129244193)
25. Jamjoom A B, Al-Hedaithy SAS, Jamjoom ZAB, et al. Intracranial mycotic infections in neurosurgical practice. Acta Neurochir (Wien) 1995; 137: 78-84.
26. Surash S, Tyagi A, de Hoog GS, et al. Cerebral phaeohyphomycosis caused by Fonsecaea monophora. Med Mycol 2005; 43: 465-472. (Pubitemid 41283051)
27. Barron MA, Sutton DA, Veve R, et al. Invasive mycotic infections caused by Chaetomium perlucidum, a new agent of cerebral phaeohyphomycosis. J Clin Microbiol 2003; 41: 5302-5307. (Pubitemid 37429966)
28. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994; 330: 263-272. (Pubitemid 24034139)
29. Greenberg R N, Mullane K, van Burik JA H, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50: 126-133. (Pubitemid 43042912)
30. Raad II, Graybill JR, Bustamante AB, et al. Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections. Clin Infect Dis 2006; 42: 1726-1734.
31. Al-Abdely H M, Najvar L, Bocanegra R, et al. SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ('Ramichloridium mackenziei'). Antimicrob Agents Chemother 2000; 44: 1159-1162. (Pubitemid 30228288)